
Methyl 3-(benzyloxy)-1-((tert-butoxycarbonyl)amino)-4-oxo-1,4-dihydropyridine-2-carboxylate
Price | Get Latest Price | |
Package | 1kg | 25kg |
Min. Order: | 1kg |
Supply Ability: | 800kg |
Update Time: | 2025-08-08 |
Product Details
Product Name: Methyl 3-(benzyloxy)-1-((tert-butoxycarbonyl)amino)-4-oxo-1,4-dihydropyridine-2-carboxylate | CAS No.: 2136287-59-5 |
Min. Order: 1kg | Purity: 0.99 |
Supply Ability: 800kg | Release date: 2025/08/08 |
Baloxavir Impurity (CAS 2136287-59-5)
Google Keywords: Baloxavir Impurity, CAS 2136287-59-5, Antiviral Drug Analysis, Influenza API QC, GMP Reference Standards
🌟 Product Overview
Baloxavir Impurity (CAS 2136287-59-5) is a high-purity reference standard critical for quality control during the synthesis of Baloxavir Marboxil, a revolutionary antiviral API targeting influenza A and B. This impurity ensures rigorous monitoring of synthesis pathways, enabling compliance with regulatory requirements for drug safety and efficacy.
Primary Function: Facilitates impurity profiling, stability studies, and batch release testing for Baloxavir Marboxil.
Applications: Antiviral API manufacturing, analytical method validation, and regulatory submissions.
✅ Key Advantages
🔹 Ultra-High Purity | ≥98.5% (HPLC/LC-MS verified) | Complies with ICH Q3A/B guidelines.
🔹 Structural Confirmation | Fully characterized by NMR, HRMS, and FTIR for traceability.
🔹 Regulatory Readiness | Supports FDA/EMA filings with comprehensive CoA (Certificate of Analysis).
🧪 Applications
Influenza Drug QC: Essential for impurity identification in Baloxavir Marboxil production.
Stability Testing: Monitors degradation pathways under ICH-recommended storage conditions.
Method Development: Validates HPLC, LC-MS, and GC protocols for API quality assurance.
📜 Quality Assurance
Testing Methods: HPLC, LC-MS, NMR, and FTIR for identity, purity, and impurity quantification.
Standards: Meets USP <1086>, EP 10.0, and ISO/IEC 17025:2017 accredited protocols.
📈 Market Trends
The global antiviral therapeutics market is projected to reach $78.5 billion by 2030 (CAGR 4.3%), fueled by increasing influenza outbreaks and demand for precision medicine. Baloxavir impurities play a vital role in accelerating the development of next-generation antiviral APIs.
Elevate your influenza drug quality control with Baloxavir Impurity – precision, compliance, and reliability for world-class pharmaceutical standards.
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/1kg |
VIP3Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2023-06-30 | |
$0.00/1KG |
VIP3Y
|
Henan Aochuang Chemical Co.,Ltd.
|
2022-10-08 | |
$1.00/1KG |
VIP8Y
|
Career Henan Chemical Co
|
2019-09-04 |
+86-+undefined-+86 13343427080
sales@biocarchem.com